Product Liability Reform: HB 1 (1987).
Provides that a product’s design is not defective if: (1)
Provides that a product’s design is not defective if: (1) an injury occurs due to the inherent characteristics of a product, where the characteristics are recognized by the ordinary person with ordinary knowledge common to the community; or (2) an injury occurs because of a design which is state of the art, unless the manufacturer acted unreasonably in introducing the product into trade or commerce. Provides that a product is not defective due to lack of warnings if the risk is open and obvious or is a risk that is a matter of common knowledge. Establishes a complete defense for manufacturers and sellers of ethical drugs and/or devices if they have supplied adequate warnings to learned intermediaries, unless the FDA requires additional warnings. Provides that a drug manufacturer shall not be liable for punitive damages if the drug was approved by the FDA.
Latest News
View all news
The Louisiana Supreme Court’s Alarming U-turn
The Pelican State deserves a judicial system that stands firmly on principles — not one swayed by the most recent political winds.
Trial Lawyers’ Latest Target: Life-Sustaining Baby Formula
Judges must recognize these cases for what they are: a cynical attempt to turn the suffering of families into a litigation jackpot.
Wall Street Journal: Junk Science Sometimes Still Prevails in Court
A recent Delaware case shows that not all states follow the Supreme Court’s 1993 Daubert ruling.
ATRA Applauds Utah AG Candidate Rudy Bautista for Signing Transparency Pledge
Republican Candidate Derek Brown Urged to Sign Pledge
Baltimore’s Opioid Lawsuit Is Wrong Approach to Overdose Crisis
Maryland taxpayers should be assured that state leadership is working in their best interests and not those of entrepreneurial trial lawyers.
ATRA Sounds Alarm on Colorado’s ‘Lawsuit Inferno’ in New Report
ATRA Declares State a ‘Lawsuit Inferno’ Amid Liability Onslaught